Synergistic antitumor effects of combination treatment with metronomic doxorubicin and VEGF-targeting RNAi nanoparticles-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Synergistic antitumor effects of combination treatment with metronomic doxorubicin and VEGF-targeting RNAi nanoparticles

Published:2017-12 Issue: Volume:267 Page:203-213
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Kwak Gijung,Jo Sung Duk,Kim Dongkyu,Kim Hyosuk,Kim Myung Goo,Kim Kwangmeyung,Kwon Ick Chan,Kim Sun Hwa

Funder

National Research Foundation of Korea

Ministry of Science, ICT and Future Planning

KIST

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference30 articles.

1. Ovarian cancer: strategies for overcoming resistance to chemotherapy;Agarwal;Nat. Rev. Cancer,2003

2. Cancer drug resistance: an evolving paradigm;Holohan;Nat. Rev. Cancer,2013

3. Hallmarks of cancer: the next generation;Hanahan;Cell,2011

4. Continuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without overt toxicity;Klement;J. Clin. Invest.,2000

5. Metronomic chemotherapy: new rationale for new directions;Pasquier;Nat. Rev. Clin. Oncol.,2010

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A review of chitosan in gene therapy: Developments and challenges;Carbohydrate Polymers;2024-01

2. Efficient ocular delivery of siRNA via pH-sensitive vehicles for corneal neovascularization inhibition;International Journal of Pharmaceutics: X;2023-12

3. Nanoarchitecture-based photothermal ablation of cancer: A systematic review;Environmental Research;2023-11

4. Advancement of regulating cellular signaling pathways in NSCLC target therapy via nanodrug;Frontiers in Chemistry;2023-09-07

5. Recent advances in targeted gene silencing and cancer therapy by nanoparticle-based delivery systems;Biomedicine & Pharmacotherapy;2023-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3